Interestingly, mutations in PBRM1 and BAP1 are largely mutually exclusive, while PBRM1 and SETD2 mutations frequently co-occur in tumors, cooperating in RCC tumorigenesis [12]. This evidence concerns the gene BAP1 and renal cell carcinoma.